- Best Practices New Normal
- Digital Dentistry
- Data Security
- Implants
- Catapult Education
- COVID-19
- Digital Imaging
- Laser Dentistry
- Restorative Dentistry
- Cosmetic Dentistry
- Periodontics
- Oral Care
- Evaluating Dental Materials
- Cement and Adhesives
- Equipment & Supplies
- Ergonomics
- Products
- Dentures
- Infection Control
- Orthodontics
- Technology
- Techniques
- Materials
- Emerging Research
- Pediatric Dentistry
- Endodontics
- Oral-Systemic Health
Forward Science Orapeutic gel gets FDA clearance
Forward Science’s non-opioid oral pain relief gel, Orapeutic ™, has received FDA clearance, the company announced in a press release this week.
Orapeutic Oral Pain Gel is manufactured to manage the pain of oral wounds, mouth sores, injuries, and ulcers of the oral mucosa. The gel also maintains a moist wound environment.
“We are proud of our previously released products and their impact on the healthcare industry, but our R&D team is always striving to develop products that meet market demands,” said Forward Science co-founder and Chief Technology Officer Brian Pikkula, PhD. “With the success of our previous product launches, we have become the industry’s leader of innovative solutions in oral healthcare. We are thrilled to receive FDA clearance for Orapeutic and are looking forward to hearing from clinicians as to how this product impacts their patients.”
With concerns of opioids being over-prescribed, Forward Science feels Orapeutic can address the epidemic by offering a pain management alternative. This is the third FDA-cleared product for the company.
Based in Houston, Forward Science is a MedTech company that focuses on moving science forward in the oral care industry. For more information, visit forwardscience.com.
America's ToothFairy Initiative Bridges Dental Care Gap for Vulnerable Children
April 18th 2024America's ToothFairy, a nonprofit organization, aids safety-net dental clinics in providing essential care to children in need, with their recent online auction raising money to support access to dental services for thousands of vulnerable kids.
Episode 31: Dentsply Sirona Implant Announcements
September 30th 2021DPR’s Editorial Director Noah Levine sat down with Gene Dorff, Dentsply Sirona’s group vice president of implants and Dr. Dan Butterman to review several big announcements the company made in the arena of implants during Dentsply Sirona World 2021 in Las Vegas.
Crest Toothpaste Honored as National Historic Chemical Landmark
April 10th 2024The American Chemical Society has designated Crest toothpaste as a National Historic Chemical Landmark, recognizing its introduction in 1955 as a transformative moment in dental care through the incorporation of fluoride chemistry.
